BioSpace News Archive

OncoBay Clinical has merged with Clinscience and Exom Group, and is now operating under a new unified brand: Kapadi

Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways together to achieve synergistic clinical benefit.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Ayala Pharmaceuticals merged with Biosight

Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures.

Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.

BRAINBox Solutions™ multi-modality approach is led by the leaders in the industry. It will include blood biomarker panels available on a point of care instrument and standard laboratory systems, as well as neurocognitive testing, to provide objective evidence of injury and prediction of patient recovery.

enVVeno Medical is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease.

Kumquat Biosciences’ vision is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients.